Statement of Renovaro Inc
14 févr. 2024 10h01 HE
|
Renovaro Biosciences Inc.
LOS ANGELES, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The following is a statement by Renovaro (Nasdaq: RENB) in response to Hindenburg's recent opinion piece: We felt compelled to comment on the shorter...
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
13 févr. 2024 09h46 HE
|
Renovaro Biosciences Inc.
A Binding LOI has been executed: GEDiCube will acquire 75% of Cyclomics at Closing.Expected breakthroughs by combining technologies in (early) cancer detection and recurrence of cancer with a single...
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine
13 févr. 2024 09h31 HE
|
Renovaro Biosciences Inc.
LOS ANGELES, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) announced today that it completed its acquisition of GEDi Cube Intl Ltd. (“GEDiCube”). Renovaro, which means renew,...
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
25 janv. 2024 12h45 HE
|
Renovaro Biosciences Inc.
LOS ANGELES, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB) (the “Company”), a biotechnology corporation focusing on cell, gene, and immunotherapy, announced today the...
Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD
16 janv. 2024 08h00 HE
|
Renovaro Biosciences Inc.
LOS ANGELES, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (Nasdaq: RENB) Dear Shareholders, Happy New Year. I write to update you on our key developments towards precision medicine...
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors
11 oct. 2023 09h25 HE
|
Renovaro Biosciences Inc.
LOS ANGELES, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), a biotechnology corporation focusing on cell, gene, and immunotherapy, has announced that Avram...
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
10 oct. 2023 08h00 HE
|
Renovaro Biosciences Inc.
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy focused on solid...
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD
02 oct. 2023 12h05 HE
|
Renovaro Biosciences Inc.
LOS ANGELES, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (Nasdaq: RENB) Dear Shareholders, I am writing to provide you with an update on our recent news of signing a definitive...
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine
02 oct. 2023 09h25 HE
|
Renovaro Biosciences Inc.
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD LOS ANGELES, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (Nasdaq: RENB) Dear Shareholders, I am writing to provide...
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
29 sept. 2023 09h15 HE
|
Renovaro Biosciences Inc.
The combined company aims to accelerate precision, personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better targeted treatments,...